Clinical Trial Update: Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Determining the Risk of Developing Contrast-Induced Nephopathy

View source ↗

Summary

This completed clinical trial evaluates neutrophil gelatinase-associated lipocalin (NGAL) as a blood marker to assess the risk of contrast-induced nephropathy i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Snippet

Sponsor: Abbott RDx Cardiometabolic | Conditions: Cardiovascular Surgery With Coronary Angiography | Status: COMPLETED